|
| |
| | | 00545 | | 18.04.1988 | | MSD Merck Sharp & Dohme AG | | | | | | | | | | | | | 08.08. | | | | 08.08. | | IP |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 01 | HBVAXPRO 40 | Injektionssuspension | Injection suspension (Hepatitidis b viri Antigenum Adnr 40 µg/ml) | J07BC01 | | | 02 | HBVAXPRO 40 Dialyse | | (Vaccinum Hepatitidis b (Adnr) Hbsag 40 mcg) | | |
|
|
|
